Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX1BM6
|
||||
| Drug Name |
[(S)-1-((S)-3-Hydroxy-2-oxo-1-phenethyl-propylcarbamoyl)-2-methyl-butyl]-carbamic acid benzyl ester
|
||||
| Synonyms |
CHEMBL99561
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C25H32N2O5
|
||||
| Canonical SMILES |
CCC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](CCc2ccccc2)C(=O)CO
|
||||
| InChI |
InChI=1S/C25H32N2O5/c1-3-18(2)23(27-25(31)32-17-20-12-8-5-9-13-20)24(30)26-21(22(29)16-28)15-14-19-10-6-4-7-11-19/h4-13,18,21,23,28H,3,14-17H2,1-2H3,(H,26,30)(H,27,31)/t18?,21-,23-/m0/s1
|
||||
| InChIKey |
SWDBTDNRUQLZFB-BUQVANKGSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.